🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Aspen Pharma Trading Limited — Licensed Medicines

53 medicines held by Aspen Pharma Trading Limited on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 53 products held by Aspen Pharma Trading Limited
MedicineActive substanceLicence holderStatus
Alkeran 2 mg Film-coated Tablets
PA1691/004/002
Melphalan Aspen Pharma Trading Limited Marketed
Alkeran 50 mg Powder and Solvent for Solution for Infusion
PA1691/004/001
Melphalan Aspen Pharma Trading Limited Marketed
Dexamethasone 2mg Tablets
PA1691/014/001
Dexamethasone Aspen Pharma Trading Limited Marketed
Diprivan 1% w/v emulsion for injection or infusion, pre-filled syringe
PA1691/022/001
Propofol Aspen Pharma Trading Limited Marketed
EMLA 5% w/w Cream
PA1691/023/001
Lidocaine, Prilocaine Aspen Pharma Trading Limited Marketed
Fondaparinux Sodium Aspen 1.5 mg/0.3 ml solution for injection, pre-filled syringe
PA1691/034/001
Fondaparinux sodium Aspen Pharma Trading Limited Not marketed
Fondaparinux sodium Aspen 10 mg/0.8 ml solution for injection, pre-filled syringe.
PA1691/034/005
Fondaparinux sodium Aspen Pharma Trading Limited Not marketed
Fondaparinux sodium Aspen 2.5 mg/0.5 ml solution for injection, pre-filled syringe.
PA1691/034/002
Fondaparinux sodium Aspen Pharma Trading Limited Not marketed
Fondaparinux sodium Aspen 5 mg/0.4 ml solution for injection, pre-filled syringe.
PA1691/034/003
Fondaparinux sodium Aspen Pharma Trading Limited Not marketed
Fondaparinux sodium Aspen 7.5 mg/0.6 ml solution for injection, pre-filled syringe.
PA1691/034/004
Fondaparinux sodium Aspen Pharma Trading Limited Not marketed
Imuran 25 mg Film-coated Tablets
PA1691/003/002
Azathioprine Aspen Pharma Trading Limited Not marketed
Imuran 50 mg Film-coated Tablets
PA1691/003/003
Azathioprine Aspen Pharma Trading Limited Marketed
Kemadrin 5 mg Tablets
PA1691/005/001
Procyclidine hydrochloride Aspen Pharma Trading Limited Marketed
Lanoxin 250 microgram Tablets
PA1691/001/004
Digoxin Aspen Pharma Trading Limited Marketed
Lanoxin 500 micrograms/2 ml Solution for Injection
PA1691/001/001
Digoxin Aspen Pharma Trading Limited Not marketed
Lanoxin PG 50 micrograms/ml Elixir
PA1691/001/002
Digoxin Aspen Pharma Trading Limited Marketed
Lanoxin PG 62.5 microgram Tablets
PA1691/001/003
Digoxin Aspen Pharma Trading Limited Marketed
Lanvis 40mg Tablets
PA1691/006/001
Tioguanine Aspen Pharma Trading Limited Not marketed
Leukeran 2 mg film-coated tablets
PA1691/007/001
Chlorambucil Aspen Pharma Trading Limited Marketed
Marcain 0.25% w/v with Adrenaline (Epinephrine, 5 micrograms per ml) (1:200,000) Solution for Injection
PA1691/025/001
Bupivacaine hydrochloride, Adrenaline tartrate Aspen Pharma Trading Limited Marketed
Marcain 0.5% w/v with Adrenaline (Epinephrine, 5 micrograms per ml) (1:200,000) Solution for Injection
PA1691/025/002
Adrenaline tartrate, Bupivacaine hydrochloride Aspen Pharma Trading Limited Not marketed
Marcain Heavy Steripack 0.5% w/v Solution for Injection
PA1691/024/003
Bupivacaine hydrochloride Aspen Pharma Trading Limited Marketed
Marcain Polyamp Steripack 0.25% w/v Solution for Injection
PA1691/024/001
Bupivacaine hydrochloride Aspen Pharma Trading Limited Marketed
Marcain Polyamp Steripack 0.5% w/v Solution for Injection
PA1691/024/002
Bupivacaine hydrochloride Aspen Pharma Trading Limited Not marketed
Mivacron 2 mg/ml Solution for Injection
PA1691/031/001
Mivacurium chloride Aspen Pharma Trading Limited Marketed
Myleran 2 mg film-coated tablets
PA1691/008/001
Busulfan Aspen Pharma Trading Limited Not marketed
Nimbex 2 mg/ml solution for injection/infusion
PA1691/030/001
Cisatracurium Besilate Aspen Pharma Trading Limited Marketed
Oroxine 100 microgram tablets
PA1691/013/004
Levothyroxine sodium Aspen Pharma Trading Limited Not marketed
Oroxine 125 microgram tablets
PA1691/013/005
Levothyroxine sodium Aspen Pharma Trading Limited Not marketed
Oroxine 150 microgram tablets
PA1691/013/006
Levothyroxine sodium Aspen Pharma Trading Limited Not marketed
Oroxine 175 microgram tablets
PA1691/013/007
Levothyroxine sodium Aspen Pharma Trading Limited Not marketed
Oroxine 200 microgram tablets
PA1691/013/008
Levothyroxine sodium Aspen Pharma Trading Limited Not marketed
Oroxine 25 microgram tablets
PA1691/013/001
Levothyroxine sodium Aspen Pharma Trading Limited Not marketed
Oroxine 50 microgram tablets
PA1691/013/002
Levothyroxine sodium Aspen Pharma Trading Limited Not marketed
Oroxine 75 microgram tablets
PA1691/013/003
Levothyroxine sodium Aspen Pharma Trading Limited Not marketed
Ovestin 1 mg per gram Vaginal Cream
PA1691/017/001
Estriol Aspen Pharma Trading Limited Marketed
Puri-Nethol 50 mg Tablets
PA1691/009/001
Mercaptopurine monohydrate Aspen Pharma Trading Limited Marketed
Septrin 80 mg/400 mg per ampoule, concentrate for solution for infusion
PA1691/010/005
Sulfamethoxazole, Trimethoprim Aspen Pharma Trading Limited Not marketed
Septrin 80 mg/400 mg Tablets
PA1691/010/001
Sulfamethoxazole, Trimethoprim Aspen Pharma Trading Limited Marketed
Septrin Adult 80 mg/400 mg per 5 ml Oral Suspension
PA1691/010/004
Sulphamethoxazole, Trimethoprim Aspen Pharma Trading Limited Marketed
Septrin Forte 160 mg/800 mg Tablets
PA1691/010/002
Sulphamethoxazole, Trimethoprim Aspen Pharma Trading Limited Marketed
Septrin Paediatric 40 mg/200 mg per 5 ml Oral Suspension
PA1691/010/003
Sulphamethoxazole, Trimethoprim Aspen Pharma Trading Limited Marketed
Sugammadex Aspen 100 mg/mL solution for injection
PA1691/036/001
Sugammadex sodium Aspen Pharma Trading Limited Marketed
Tracrium 10 mg/ml solution for injection or infusion, vials
PA1691/029/002
Atracurium besilate Aspen Pharma Trading Limited Marketed
Tracrium 10 mg/ml, solution for injection or infusion, ampoules
PA1691/029/001
Atracurium besilate Aspen Pharma Trading Limited Marketed
Ultiva 1 mg Powder for Concentrate for Solution for Infusion
PA1691/032/001
Remifentanil hydrochloride Aspen Pharma Trading Limited Marketed
Ultiva 2 mg Powder for Concentrate for Solution for Infusion
PA1691/032/002
Remifentanil Aspen Pharma Trading Limited Marketed
Ultiva 5 mg Powder for Concentrate for Solution for Infusion
PA1691/032/003
Remifentanil Aspen Pharma Trading Limited Marketed
Xylocaine 10 mg/delivered dose Mucosal Spray
PA1691/028/001
Lidocaine Aspen Pharma Trading Limited Marketed
Xylocaine 2% with Adrenaline (Epinephrine) (1:200,000) Solution for Injection
PA1691/027/001
Lidocaine hydrochloride, Adrenaline Aspen Pharma Trading Limited Marketed
1 2
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.